SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Bio-Chem Pharma (BCHXF)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: jbershad who wrote (22)8/19/1996 8:57:00 AM
From: Constant Reader   of 43
 
Jerry:

Scripps is a rather famous medical institution located in San Diego County, CA. Research into one of the upcoming Protease Inhibitors, Viracept, from Agouron Pharmaceuticals, was done there.

That said, I am mystified by the responses of our "doctor" friend. The 3TC/AZT combination has been used by many for a while. The triple drug combination IS in use.

I do not know of many physicians or patients willing to sit around and wait for the CDC to get around to saying anything. People are being treated aggressively whenever possible/desired. Few patients have the luxury of time to find out what may or may not be best. Most will take any risk that has such apparent benefits, even if it eventually turns out to be short-term.

Re: BCHXF, I have been thinking that is appears "fully priced" for the moment given their royalty agreement. As for PI's, the best coming to market is coming from AGPH. Has fewest side-effects of the new group out.

We both know these drugs are not in competition with each other, but work best in combination with each other. If was our "doctor's" patient, I would have sought a better-informed and less cautious physician about six months ago at the latest.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext